{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:40:33Z","timestamp":1790419233949,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016045","name":"University of Central Punjab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cyto.2023.156154","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T16:47:03Z","timestamp":1676911623000},"page":"156154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Translational implications of humoral and cellular immune dysfunction in granulomatosis with polyangiitis"],"prefix":"10.1016","volume":"164","author":[{"given":"Harinder","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabyasachi","family":"Senapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.cyto.2023.156154_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197319","article-title":"Immunopathogenesis of ANCA-Associated Vasculitis","volume":"21","author":"Kronbichler","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0015","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar4247","article-title":"Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA)","volume":"15","author":"Abdulahad","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2023.156154_b0330","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2014.01.028","article-title":"Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis)","volume":"48\u201349","author":"Lutalo","year":"2014","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.cyto.2023.156154_b0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/0394632015617063","article-title":"Clinic manifestations in granulomatosis with polyangiitis","volume":"29","author":"Greco","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13052-017-0364-x","article-title":"ANCA-associated vasculitis in childhood: recent advances","volume":"43","author":"Calatroni","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.cyto.2023.156154_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-022-06267-z","article-title":"BVAS version 3 and BVAS\/GPA: standing on the same line?","author":"Ahn","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/rheumatology\/37.1.57","article-title":"Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI)","volume":"37","author":"Exley","year":"1998","journal-title":"Br. J. Rheumatol."},{"issue":"11","key":"10.1016\/j.cyto.2023.156154_b0105","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.autrev.2014.08.017","article-title":"Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment","volume":"13","author":"Comarmond","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.cyto.2023.156154_b0420","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156154_b0615","doi-asserted-by":"crossref","first-page":"R203","DOI":"10.1186\/ar4041","article-title":"Aberrant cytokine pattern of the nasal mucosa in granulomatosis with polyangiitis","volume":"14","author":"Wohlers","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"6 Pt 2","key":"10.1016\/j.cyto.2023.156154_b0465","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.lpm.2015.04.007","article-title":"Recent pathogenetic advances in ANCA-associated vasculitis","volume":"44","author":"Pendergraft","year":"2015","journal-title":"Presse Med."},{"issue":"5","key":"10.1016\/j.cyto.2023.156154_b0520","doi-asserted-by":"crossref","first-page":"e12958","DOI":"10.1111\/sji.12958","article-title":"Proteinase 3 Autoreactivity in Anti-Neutrophil Cytoplasmic Antibody-associated vasculitis-Immunological versus clinical features","volume":"92","author":"Sharma","year":"2020","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0445","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1038\/s41467-019-11255-0","article-title":"A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity","volume":"10","author":"Ooi","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0450","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5152\/eurjrheum.2015.0043","article-title":"Updates in ANCA-associated vasculitis","volume":"3","author":"Pagnoux","year":"2016","journal-title":"Eur. J. Rheumatol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156154_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10122715","article-title":"Chemokine\/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis","volume":"10","author":"Muller-Deile","year":"2021","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.cyto.2023.156154_b0635","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071773","article-title":"Immune Cells Profiling in ANCA-Associated Vasculitis Patients-Relation to Disease Activity","volume":"10","author":"Zabinska","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2023.156154_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631055","article-title":"New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis","volume":"12","author":"Nozaki","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"4","key":"10.1016\/j.cyto.2023.156154_b0350","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/ckj\/sfz029","article-title":"T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach","volume":"12","author":"Martinez Valenzuela","year":"2019","journal-title":"Clin. Kidney J."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0475","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/08916934.2019.1631812","article-title":"Neutrophil extracellular traps generation and degradation in patients with granulomatosis with polyangiitis and systemic lupus erythematosus","volume":"52","author":"Pruchniak","year":"2019","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-Associated Vasculitis: Core Curriculum 2020","volume":"75","author":"Geetha","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cyto.2023.156154_b0040","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.3389\/fimmu.2019.02617","article-title":"Neutrophil Extracellular Traps Induce Tissue-Invasive Monocytes in Granulomatosis With Polyangiitis","volume":"10","author":"Akiyama","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2023.156154_b0140","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00296-021-04966-5","article-title":"Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype","volume":"41","author":"Dominguez-Quintana","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0200","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12016-007-8057-7","article-title":"B-cell depletion in Wegener's granulomatosis","volume":"34","author":"Hinze","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2023.156154_b0340","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/14728222.2020.1821647","article-title":"The BAFF \/ APRIL system as therapeutic target in multiple sclerosis","volume":"24","author":"Magliozzi","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"10","key":"10.1016\/j.cyto.2023.156154_b0365","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41584-018-0065-x","article-title":"B cell therapy in ANCA-associated vasculitis: current and emerging treatment options","volume":"14","author":"McClure","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cyto.2023.156154_b0295","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13075-016-0978-1","article-title":"Regulatory and effector B cell cytokine production in patients with relapsing granulomatosis with polyangiitis","volume":"18","author":"Land","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.cyto.2023.156154_b0325","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.160.7.3602","article-title":"Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10","volume":"160","author":"Ludviksson","year":"1998","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2023.156154_b0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940500921X","article-title":"Pathogenesis of Wegener's granulomatosis: current concepts","volume":"7","author":"Sarraf","year":"2005","journal-title":"Expert Rev. Mol. Med."},{"issue":"6","key":"10.1016\/j.cyto.2023.156154_b0250","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrrheum.2012.205","article-title":"The role of IL-17-secreting mast cells in inflammatory joint disease","volume":"9","author":"Kenna","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156154_b0550","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/eji.201646810","article-title":"Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis","volume":"47","author":"Szczeklik","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156154_b0145","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","article-title":"IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells","volume":"175","author":"Ettinger","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0395","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2004.12.042","article-title":"Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease","volume":"128","author":"Monteleone","year":"2005","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cyto.2023.156154_b0215","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.ophtha.2015.04.016","article-title":"Tissue Interleukin-17 and Interleukin-23 as Biomarkers for Orbital Granulomatosis with Polyangiitis","volume":"122","author":"Isa","year":"2015","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.cyto.2023.156154_b0050","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/rheumatology\/kes163","article-title":"Elevated interleukin-32 expression in granulomatosis with polyangiitis","volume":"51","author":"Bae","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cyto.2023.156154_b0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.02.025","article-title":"Interleukin 32, inflammation and cancer","volume":"174","author":"Hong","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.cyto.2023.156154_b0275","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1684\/ecn.2019.0439","article-title":"Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings","volume":"30","author":"Krajewska Wojciechowska","year":"2019","journal-title":"Eur. Cytokine Netw."},{"issue":"9","key":"10.1016\/j.cyto.2023.156154_b0115","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J. Immunol."},{"issue":"2\u20136","key":"10.1016\/j.cyto.2023.156154_b0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1615\/CritRevImmunol.v37.i2-6.30","article-title":"Functions of IL-4 and Control of Its Expression","volume":"37","author":"Brown","year":"2017","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.cyto.2023.156154_b0135","series-title":"The Cytokines of the Immune System","first-page":"143","article-title":"Chapter 6 - Cytokines of the Immune System: Interleukins","author":"Dembic","year":"2015"},{"key":"10.1016\/j.cyto.2023.156154_b0345","series-title":"The Immune Response","first-page":"463","article-title":"17 - Cytokines and Cytokine Receptors","author":"Mak","year":"2006"},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semarthrit.2015.02.002","article-title":"Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab","volume":"45","author":"Berti","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.cyto.2023.156154_b0555","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156154_b0610","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jbspin.2017.05.004","article-title":"Granulomatosis with polyangiitis (Wegener granulomatosis): A proteinase-3 driven disease?","volume":"85","author":"Witko-Sarsat","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.cyto.2023.156154_b0320","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1beta secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.cyto.2023.156154_b0485","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cyto.2014.10.005","article-title":"Predominance of PR3 specific immune response and skewed TH17 vs. T-regulatory milieu in active granulomatosis with polyangiitis","volume":"71","author":"Rani","year":"2015","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.cyto.2023.156154_b0110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/eji.201746986","article-title":"Th17 and Treg lymphocytes as cellular biomarkers of disease activity in Granulomatosis with Polyangiitis","volume":"47","author":"Cosmi","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156154_b0410","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126474","article-title":"Granulomatous Inflammation in ANCA-Associated Vasculitis","volume":"22","author":"Muller","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2023.156154_b0280","article-title":"Serum cytokines in ANCA-associated vasculitis: Correlation with disease-related clinical and laboratory findings","author":"Krajewska Wojciechowska","year":"2020","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.cyto.2023.156154_b0600","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molimm.2019.11.010","article-title":"Reduced activated regulatory T cells and imbalance of Th17\/activated Treg cells marks renal involvement in ANCA-associated vasculitis","volume":"118","author":"Wang","year":"2020","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156154_b0025","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.ki.5001670","article-title":"Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis","volume":"70","author":"Abdulahad","year":"2006","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.cyto.2023.156154_b0010","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/art.24747","article-title":"Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Abdulahad","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0315","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13075-021-02576-x","article-title":"Altered circulating CCR6(+)and CXCR3(+) T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis","volume":"23","author":"Liao","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0370","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010387","article-title":"B Lineage Cells in ANCA-Associated Vasculitis","volume":"23","author":"Merino-Vico","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0595","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13075-022-02796-9","article-title":"Increased frequency of IgD-CD27(hi)CD38(hi) B cells and its association with the renal involvement in ANCA-associated vasculitis","volume":"24","author":"Wang","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cyto.2023.156154_b0580","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3389\/fimmu.2019.02221","article-title":"CD27(+)CD38(hi) B Cell Frequency During Remission Predicts Relapsing Disease in Granulomatosis With Polyangiitis Patients","volume":"10","author":"von Borstel","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156154_b0495","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.it.2015.12.005","article-title":"Re-examining the Nature and Function of Self-Reactive T cells","volume":"37","author":"Richards","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cyto.2023.156154_b0085","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fimmu.2019.01198","article-title":"Autoreactive T-Lymphocytes in Inflammatory Skin Diseases","volume":"10","author":"Boehncke","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0265","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/imm.12754","article-title":"CTLA-4 expressed by FOXP3(+) regulatory T cells prevents inflammatory tissue attack and not T-cell priming in arthritis","volume":"152","author":"Klocke","year":"2017","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.cyto.2023.156154_b0020","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/art.22692","article-title":"Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission","volume":"56","author":"Abdulahad","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cyto.2023.156154_b0385","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0490","doi-asserted-by":"crossref","first-page":"8273","DOI":"10.1038\/s41598-019-44636-y","article-title":"Unraveling the identity of FoxP3+ regulatory T cells in Granulomatosis with Polyangiitis patients","volume":"9","author":"Reijnders","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cyto.2023.156154_b0425","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nri.2017.19","article-title":"Mechanisms of central tolerance for B cells","volume":"17","author":"Nemazee","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2023.156154_b0630","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J. Exp. Med."},{"issue":"22","key":"10.1016\/j.cyto.2023.156154_b0070","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150999","article-title":"Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis","volume":"6","author":"Berti","year":"2021","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.cyto.2023.156154_b0460","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/03009742.2014.894568","article-title":"Decreased tumour necrosis factor-alpha production by monocytes of granulomatosis with polyangiitis","volume":"43","author":"Park","year":"2014","journal-title":"Scand. J. Rheumatol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156154_b0080","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/ard.2003.017954","article-title":"Expression of matrix metalloproteinases in patients with Wegener's granulomatosis","volume":"63","author":"Bjerkeli","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0525","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000506670","article-title":"Palisaded Neutrophilic and Granulomatous Dermatitis in a Patient with Granulomatosis with Polyangiitis","volume":"12","author":"Akagawa","year":"2020","journal-title":"Case Rep. Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13075-017-1310-4","article-title":"M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitis","volume":"19","author":"de Souza","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0640","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2215\/CJN.03230314","article-title":"M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN","volume":"10","author":"Zhao","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cyto.2023.156154_b0435","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/09629350400003100","article-title":"Circulating cytokine profile in anti-neutrophilic cytoplasmatic autoantibody-associated vasculitis: prediction of outcome?","volume":"13","author":"Ohlsson","year":"2004","journal-title":"Mediators Inflamm."},{"issue":"10","key":"10.1016\/j.cyto.2023.156154_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102911","article-title":"Monocytes and macrophages in ANCA-associated vasculitis","volume":"20","author":"Vegting","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.cyto.2023.156154_b0440","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/intimm\/dxy054","article-title":"Macrophages in inflammation, repair and regeneration","volume":"30","author":"Oishi","year":"2018","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0005","doi-asserted-by":"crossref","first-page":"e32439","DOI":"10.1371\/journal.pone.0032439","article-title":"Decreased neutrophil apoptosis in quiescent ANCA-associated systemic vasculitis","volume":"7","author":"Abdgawad","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cyto.2023.156154_b0100","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1172\/JCI40034","article-title":"Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis","volume":"120","author":"Ciavatta","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0355","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00281-022-00920-0","article-title":"Mechanisms of vascular damage in ANCA vasculitis","volume":"44","author":"Massicotte-Azarniouch","year":"2022","journal-title":"Semin. Immunopathol."},{"issue":"8","key":"10.1016\/j.cyto.2023.156154_b0165","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/ATVBAHA.111.242859","article-title":"Neutrophil extracellular trap (NET) impact on deep vein thrombosis","volume":"32","author":"Fuchs","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2023.156154_b0455","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fimmu.2017.00439","article-title":"Neutrophil Extracellular Traps Contain Selected Antigens of Anti-Neutrophil Cytoplasmic Antibodies","volume":"8","author":"Panda","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2023.156154_b0255","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2023.156154_b0195","article-title":"Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis","volume":"12","author":"Hashimoto","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2023.156154_b0245","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ncprheum0355","article-title":"Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides","volume":"2","author":"Kallenberg","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.cyto.2023.156154_b0535","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fimmu.2016.00256","article-title":"Neutrophil Extracellular Traps in ANCA-Associated Vasculitis","volume":"7","author":"Soderberg","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2023.156154_b0235","article-title":"Pentraxin-3 - a potential biomarker in ANCA-associated vasculitis","volume":"1\u20139","author":"Jonasdottir","year":"2022","journal-title":"Scand. J. Rheumatol."},{"issue":"10","key":"10.1016\/j.cyto.2023.156154_b0155","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.4049\/jimmunol.178.10.6573","article-title":"Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling","volume":"178","author":"Fan","year":"2007","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2023.156154_b0590","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.autrev.2015.07.010","article-title":"Emerging role of high mobility group box 1 in ANCA-associated vasculitis","volume":"14","author":"Wang","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2023.156154_b0375","doi-asserted-by":"crossref","unstructured":"P.A. Merkel, G.H. Lo, J.T. Holbrook, A.K. Tibbs, N.B. Allen, J.C. Davis Jr., G.S. Hoffman, W.J. McCune, E.W. St Clair, U. Specks, R. Spiera, M. Petri, J.H. Stone, G. Wegener's Granulomatosis Etanercept Trial Research, Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann. Intern. Med. 142(8) (2005) 620-626. Doi: 10.7326\/0003-4819-142-8-200505030-00011.","DOI":"10.7326\/0003-4819-142-8-200505030-00011"},{"issue":"12","key":"10.1016\/j.cyto.2023.156154_b0380","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1007\/s10067-021-05790-9","article-title":"Mechanisms of thrombosis in ANCA-associated vasculitis","volume":"40","author":"Misra","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2023.156154_b0120","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1586\/1744666X.2013.811052","article-title":"Current understanding of the pathogenesis of granulomatosis with polyangiitis (Wegener's)","volume":"9","author":"Csernok","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.cyto.2023.156154_b0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0463.2009.02474.x","article-title":"Granuloma formation in ANCA-associated vasculitides","volume":"Suppl(127)","author":"Lamprecht","year":"2009","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/j.cyto.2023.156154_b0045","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/PAP.0000000000000154","article-title":"Pathophysiology of ANCA-associated Vasculitis","volume":"24","author":"Al-Hussain","year":"2017","journal-title":"Adv. Anat. Pathol."},{"issue":"2","key":"10.1016\/j.cyto.2023.156154_b0310","first-page":"65","article-title":"Pathophysiology of ANCA-associated vasculitis","volume":"56","author":"Lenka","year":"2020","journal-title":"Cesk. Patol."},{"key":"10.1016\/j.cyto.2023.156154_b0585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1196\/annals.1361.042","article-title":"Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions? Granulomas as potential lymphoid tissue maintaining autoantibody production","volume":"1051","author":"Voswinkel","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.cyto.2023.156154_b0605","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2010.472","article-title":"New pathophysiological insights and treatment of ANCA-associated vasculitis","volume":"79","author":"Wilde","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.cyto.2023.156154_b0075","doi-asserted-by":"crossref","unstructured":"A. Berti, R. Warner, K. Johnson, D. Cornec, D.R. Schroeder, B.F. Kabat, C.A. Langford, C.G.M. Kallenberg, P. Seo, R.F. Spiera, E.W. St Clair, F.C. Fervenza, J.H. Stone, P.A. Monach, U. Specks, P.A. Merkel, R.-I.R. Group, The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis, J. Autoimmun 105 (22019) 102302.","DOI":"10.1016\/j.jaut.2019.07.001"},{"key":"10.1016\/j.cyto.2023.156154_b0160","unstructured":"A. S. o. N. C. From the American Association of Neurological Surgeons, C. I. R. A. C. o. N. S. E. S. o. M. I. N. T. E. S. o. N. E. S. O. S. f. C. A. Interventional Radiology Society of Europe, S. o. I. R. S. o. N. S. Interventions, O. World Stroke, D. Sacks, B. Baxter, B. C. V. Campbell, J. S. Carpenter, C. Cognard, D. Dippel, M. Eesa, U. Fischer, K. Hausegger, J.A. Hirsch, M. Shazam Hussain, O. Jansen, M.V. Jayaraman, A. A. Khalessi, B. W. Kluck, S. Lavine, P. M. Meyers, S. Ramee, D. A. Rufenacht, C.M. Schirmer, D. Vorwerk, Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke, Int. J. Stroke 13(6) (2018) 612-632. Doi: 10.1177\/1747493018778713."},{"issue":"7","key":"10.1016\/j.cyto.2023.156154_b0575","doi-asserted-by":"crossref","first-page":"e0235743","DOI":"10.1371\/journal.pone.0235743","article-title":"Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production","volume":"15","author":"von Borstel","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12016-007-8056-8","article-title":"Pathways to ANCA production: from differentiation of dendritic cells by proteinase 3 to B lymphocyte maturation in Wegener's granuloma","volume":"34","author":"Csernok","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.cyto.2023.156154_b0415","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1038\/srep02960","article-title":"IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis","volume":"3","author":"Nakayama","year":"2013","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cyto.2023.156154_b0620","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2013020143","article-title":"C5a receptor (CD88) blockade protects against MPO-ANCA GN","volume":"25","author":"Xiao","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.cyto.2023.156154_b0210","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.ki.5002103","article-title":"Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice","volume":"71","author":"Huugen","year":"2007","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.cyto.2023.156154_b0400","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11926-021-01010-0","article-title":"Novel Therapies for ANCA-associated Vasculitis","volume":"23","author":"Monti","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0480","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jbspin.2018.09.002","article-title":"Targeted immunotherapy strategies in ANCA-associated vasculitis","volume":"86","author":"Puechal","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.cyto.2023.156154_b0510","article-title":"Strategies for effective treatment of ANCA-associated vasculitides with fewer side effects","volume":"1\u201312","author":"Schonermarck","year":"2021","journal-title":"Nephrologe"},{"key":"10.1016\/j.cyto.2023.156154_b0540","doi-asserted-by":"crossref","unstructured":"J.H. Stone, P.A. Merkel, R. Spiera, P. Seo, C.A. Langford, G.S. Hoffman, C.G. Kallenberg, E.W. St Clair, A. Turkiewicz, N.K. Tchao, L. Webber, L. Ding, L.P. Sejismundo, K. Mieras, D. Weitzenkamp, D. Ikle, V. Seyfert-Margolis, M. Mueller, P. Brunetta, N.B. Allen, F.C. Fervenza, D. Geetha, K.A. Keogh, E.Y. Kissin, P.A. Monach, T. Peikert, C. Stegeman, S. R. Ytterberg, U. Specks, R.-I. R. Group, Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N. Engl. J. Med. 363(3) (2010) 221-232. Doi: 10.1056\/NEJMoa0909905.","DOI":"10.1056\/NEJMoa0909905"},{"issue":"6","key":"10.1016\/j.cyto.2023.156154_b0240","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial","volume":"74","author":"Jones","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2023.156154_b0560","doi-asserted-by":"crossref","unstructured":"S. Thietart, A. Karras, J.F. Augusto, C. Philipponnet, P.L. Carron, X. Delbrel, R. Mesbah, G. Blaison, P. Duffau, K. El Karoui, P. Smets, J. London, L. Mouthon, L. Guillevin, B. Terrier, X. Puechal, G. French Vasculitis Study, Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, JAMA Netw. Open, 5(7) (2022) e2220925. Doi: 10.1001\/jamanetworkopen.2022.20925.","DOI":"10.1001\/jamanetworkopen.2022.20925"},{"issue":"2","key":"10.1016\/j.cyto.2023.156154_b0335","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.intimp.2015.04.023","article-title":"Biological drugs in ANCA-associated vasculitis","volume":"27","author":"Lutalo","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cyto.2023.156154_b0545","doi-asserted-by":"crossref","unstructured":"J.H. Stone, G. Wegener's Granulomatosis Etanercept Trial Research, Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum, 48(8) (2003) 2299-2309. Doi: 10.1002\/art.11075.","DOI":"10.1002\/art.11075"},{"key":"10.1016\/j.cyto.2023.156154_b0055","first-page":"CD008333","article-title":"Anti-cytokine targeted therapies for ANCA-associated vasculitis","volume":"9","author":"Bala","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0565","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13317-020-00147-9","article-title":"Sustained clinical remission under infliximab\/rituximab combination therapy in a patient with granulomatosis with polyangiitis","volume":"12","author":"Valor-Mendez","year":"2021","journal-title":"Auto Immun Highlights"},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0505","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13256-022-03370-2","article-title":"Infliximab therapy of relapsing tracheal stenosis in a pediatric patient with granulomatosis with polyangiitis: a case report","volume":"16","author":"Schnell","year":"2022","journal-title":"J. Med. Case Reports"},{"issue":"10","key":"10.1016\/j.cyto.2023.156154_b0305","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1093\/ndt\/gfq187","article-title":"Prospective study of TNFalpha blockade with adalimumab in ANCA-associated systemic vasculitis with renal involvement","volume":"25","author":"Laurino","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0470","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.41407","article-title":"New Therapeutic Targets in Antineutrophil Cytoplasm Antibody-Associated Vasculitis","volume":"73","author":"Prendecki","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2023.156154_b0300","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/annrheumdis-2013-204164","article-title":"An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)","volume":"73","author":"Langford","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2023.156154_b0270","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00281-013-0362-z","article-title":"Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis)","volume":"35","author":"Korkmaz","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.cyto.2023.156154_b0515","doi-asserted-by":"crossref","unstructured":"S. Seren, M. Rashed Abouzaid, C. Eulenberg-Gustavus, J. Hirschfeld, H. Nasr Soliman, U. Jerke, K. N'Guessan, S. Dallet-Choisy, A. Lesner, C. Lauritzen, B. Schacher, P. Eickholz, N. Nagy, M. Szell, C. Croix, M.C. Viaud-Massuard, A. Al Farraj Aldosari, S. Ragunatha, M. Ibrahim Mostafa, F. Giampieri, M. Battino, H. Cornillier, G. Lorette, J. L. Stephan, C. Goizet, J. Pedersen, F. Gauthier, D. E. Jenne, S. Marchand-Adam, I. L. Chapple, R. Kettritz, B. Korkmaz, Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis. J. Biol. Chem. 293(32) (2018) 12415-12428. Doi: 10.1074\/jbc.RA118.001922.","DOI":"10.1074\/jbc.RA118.001922"},{"key":"10.1016\/j.cyto.2023.156154_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.571933","article-title":"Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies","volume":"12","author":"Granel","year":"2021","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.cyto.2023.156154_b0390","first-page":"2652","article-title":"Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity","volume":"117","author":"Molinaro","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"15","key":"10.1016\/j.cyto.2023.156154_b0530","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155497","article-title":"Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases","volume":"21","author":"Skytthe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2023.156154_b0360","doi-asserted-by":"crossref","unstructured":"S. Mcadoo, M. Prendecki, T. Turner-Stokes, G. Bhangal, T. Cook, F. Tam, C. Pusey, 212. FOSTAMATINIB TREATMENT OF A NEW MODEL OF MPO-ANCA VASCULITIS IN WKY RATS INDUCED BY ADMINISTRATION OF A SUBNEPHRITOGENIC DOSE OF NEPHROTOXIC SERUM AFTER IMMUNIZATION WITH HUMAN MYELOPEROXIDASE. Rheumatology, 58(Supplement_2) (2019) kez061. 027.","DOI":"10.1093\/rheumatology\/kez061.027"},{"issue":"10","key":"10.1016\/j.cyto.2023.156154_b0060","doi-asserted-by":"crossref","first-page":"e0164646","DOI":"10.1371\/journal.pone.0164646","article-title":"Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study","volume":"11","author":"Bekker","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cyto.2023.156154_b0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/mr\/roab104","article-title":"Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"32","author":"Harigai","year":"2022","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.cyto.2023.156154_b0225","doi-asserted-by":"crossref","unstructured":"D. R. W. Jayne, A.N. Bruchfeld, L. Harper, M. Schaier, M.C. Venning, P. Hamilton, V. Burst, F. Grundmann, M. Jadoul, I. Szombati, V. Tesar, M. Segelmark, A. Potarca, T.J. Schall, P. Bekker, C. S. Group, Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis. J Am. Soc. Nephrol, 28(9) (2017) 2756-2767. Doi: 10.1681\/ASN.2016111179.","DOI":"10.1681\/ASN.2016111179"},{"key":"10.1016\/j.cyto.2023.156154_b0230","doi-asserted-by":"crossref","unstructured":"D.R.W. Jayne, P.A. Merkel, T.J. Schall, P. Bekker, A.S. Group, Avacopan for the Treatment of ANCA-Associated Vasculitis. N. Engl. J. Med. 384(7) (2021) 599-609. Doi: 10.1056\/NEJMoa2023386.","DOI":"10.1056\/NEJMoa2023386"},{"issue":"1","key":"10.1016\/j.cyto.2023.156154_b0625","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-021-02415-z","article-title":"Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis","volume":"23","author":"Yamada","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"38","key":"10.1016\/j.cyto.2023.156154_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/PNXB5040","article-title":"Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT","volume":"26","author":"Jayne","year":"2022","journal-title":"Health Technol. Assess."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623000327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623000327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:49:08Z","timestamp":1760910548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623000327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":128,"alternative-id":["S1043466623000327"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156154","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational implications of humoral and cellular immune dysfunction in granulomatosis with polyangiitis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156154"}}